首页> 外文期刊>Chest >Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients: Findings From the International Medical Prevention Registry on Venous Thromboembolism
【24h】

Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients: Findings From the International Medical Prevention Registry on Venous Thromboembolism

机译:急性病住院医疗患者的静脉血栓栓塞预防:国际医学预防性注册表关于静脉血栓栓塞的发现

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Evidence-based guidelines recommend that acutely ill hospitalized medical patientsnwho are at risk of venous thromboembolism (VTE) should receive prophylaxis. Our aim was toncharacterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patientsnenrolled in the International Medical Prevention Registry on Venous Thromboembolism (IM-nPROVE).nMethods: IMPROVE is an ongoing, multinational, observational study. Participating hospitalsnenroll the first 10 consecutive eligible acutely ill medical patients each month. Patient manage-nment is determined by the treating physicians. An analysis of data on VTE prophylaxis practicesnis presented.nResults: From July 2002 to September 30, 2006, 15,156 patients were enrolled from 52 hospitalsnin 12 countries, of whom 50% received in-hospital pharmacologic and/or mechanical VTEnprophylaxis. In the United States and other participating countries, 52% and 43% of patients,nrespectively, should have received prophylaxis according to guideline recommendations from thenAmerican College of Chest Physicians (ACCP). Only approximately 60% of patients who eithernmet the ACCP criteria for requiring prophylaxis or were eligible for enrollment in randomizednclinical trials that have shown the benefits of pharmacologic prophylaxis actually receivednprophylaxis. Practices varied considerably. Intermittent pneumatic compression was the mostncommon form of medical prophylaxis utilized in the United States, although it was used verynrarely in other countries (22% vs 0.2%, respectively). Unfractionated heparin was the mostnfrequent pharmacologic approach used in the United States (21% of patients), with low-nmolecular-weight heparin used most frequently in other participating countries (40%). There wasnalso variable use of elastic stockings in the United States and other participating countries (3% vsn7%, respectively).nConclusions: Our data suggest that physicians’ practices for providing VTE prophylaxis to acutelynill hospitalized medical patients are suboptimal and highlight the need for improved implemen-ntation of existing evidence-based guidelines in hospitals.
机译:背景:基于证据的指南建议对有静脉血栓栓塞(VTE)风险的急病住院医疗患者进行预防。我们的目标是通过国际静脉血栓栓塞症(IM-nPROVE)登记的国际急诊住院医疗患者,对预防急症住院的患者进行VTE预防的临床实践。n方法:IMPROVE是一项正在进行的,跨国的,观察性研究。参与的医院每月登记前十名连续的合格急性病患者。病人的管理由主治医师决定。结果:从2002年7月至2006年9月30日,来自12个国家的52家医院的15156例患者入组,其中50%接受了院内药理和/或机械性VT预防。在美国和其他参与国中,分别应根据当时的美国胸科医师学院(ACCP)的指南建议进行预防性治疗的患者分别为52%和43%。只有约60%的患者未达到ACCP要求的预防标准或有资格参加显示药物预防的益处的随机临床试验而实际上接受了预防。实践差异很大。在美国,间歇性气动加压是医学上最常用的预防方法,尽管在其他国家也很少使用(分别为22%和0.2%)。在美国(21%的患者)使用普通肝素是最常用的药理学方法,在其他参与国(40%)使用低分子量肝素的频率最高。在美国和其他参与国中,弹性袜的使用也存在差异(分别为3%和7%)。n结论:我们的数据表明,医生为急诊住院的医疗患者提供VTE预防的做法并不理想,并强调需要改进在医院中实施现有的循证指南。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号